$SOND
Sonder Holdings Inc. Stock $sond

$sond Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000181939523000074 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$157.4M	$120.7M	$80.47M
YoY Change	29.74%	50.05%	154.98%
Cost Of Revenue	$93.24M	$15.63M	$10.30M
YoY Change	534.87%	51.84%
Gross Profit	$64.16M	$105.1M	$70.17M
YoY Change	-39.83%	49.79%
Gross Profit Margin	40.76%	87.05%	87.2%
Selling, General & Admin	$48.40M	$48.58M	$46.44M
YoY Change	10.78%	4.61%	33.99%
% of Gross Profit	75.44%	46.22%	66.18%
Research & Development	$5.563M	$6.580M	$7.625M
YoY Change	-31.22%	-13.7%	129.74%
% of Gross Profit	8.67%	6.26%	10.87%
Depreciation & Amortization	$5.978M	$7.048M	$5.630M
YoY Change	-0.3%	25.19%	36.68%
% of Gross Profit	9.32%	6.71%	8.02%
Operating Expenses	$53.96M	$55.16M	$54.07M
YoY Change	4.22%	2.02%	42.36%
Operating Profit	-$42.01M	-$84.74M	-$95.76M
YoY Change	-37.93%	-11.51%	34.79%
Interest Expense	-$6.155M	-$5.707M	-$8.202M
YoY Change	40.46%	-30.42%	114.32%
% of Operating Profit
Other Income/Expense, Net	-$3.133M	-$1.607M	$118.2M
YoY Change	-113.04%	-101.36%	-1682.37%
Pretax Income	-$45.15M	-$86.35M	$22.42M
YoY Change	3.41%	-485.1%	-128.56%
Income Tax	$200.0K	$81.00K	$31.00K
% Of Pretax Income			0.14%
Net Earnings	-$45.33M	-$86.43M	$22.39M
YoY Change	3.55%	-485.99%	-128.51%
Net Earnings / Revenue	-28.8%	-71.59%	27.83%
Basic Earnings Per Share	-$0.21	-$0.39	$0.11
Diluted Earnings Per Share	-$0.21	-$0.39	-$0.18
COMMON SHARES
Basic Shares Outstanding	219.3M shares	219.3M shares	176.3M shares
Diluted Shares Outstanding	218.0M shares	219.1M shares	171.8M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$177.4M	$218.0M	$406.3M
YoY Change	-50.64%	-46.36%	145024.29%
Cash & Equivalents	$177.4M	$218.0M	$406.3M
Short-Term Investments
Other Short-Term Assets	$11.52M	$12.71M	$18.52M
YoY Change	-39.38%	-31.37%	923.09%
Inventory
Prepaid Expenses
Receivables	$14.04M	$6.990M	$1.336M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$253.9M	$271.2M	$444.7M
YoY Change	-36.41%	-39.01%	21177.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.62M	$35.43M	$35.24M
YoY Change	-11.2%	0.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.67M	$13.79M	$15.61M
YoY Change	-11.16%	-11.63%
Total Long-Term Assets	$1.354B	$1.250B	$1.185B
YoY Change	16.7%	5.54%	163.26%
TOTAL ASSETS
Total Short-Term Assets	$253.9M	$271.2M	$444.7M
Total Long-Term Assets	$1.354B	$1.250B	$1.185B
Total Assets	$1.608B	$1.521B	$1.629B
YoY Change	3.11%	-6.62%	260.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.88M	$14.09M	$16.11M
YoY Change	28.89%	-12.51%
Accrued Expenses	$18.56M	$18.23M	$25.31M
YoY Change	-28.03%	-27.98%	1452.94%
Deferred Revenue	$59.86M	$58.42M	$34.07M
YoY Change	58.57%	71.49%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$297.3M	$279.7M	$229.9M
YoY Change	22.05%	21.66%	896.28%
LONG-TERM LIABILITIES
Long-Term Debt	$186.9M	$179.7M	$156.7M
YoY Change	15.87%	14.64%
Other Long-Term Liabilities	$1.106M	$2.043M	$36.60M
YoY Change	-45.6%	-94.42%	132.4%
Total Long-Term Liabilities	$188.0M	$181.7M	$193.3M
YoY Change	15.11%	-6.01%	1127.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$297.3M	$279.7M	$229.9M
Total Long-Term Liabilities	$188.0M	$181.7M	$193.3M
Total Liabilities	$1.744B	$1.618B	$1.494B
YoY Change	19.72%	8.31%	3748.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.112B	-$1.067B	-$792.4M
YoY Change	33.02%	34.65%
Common Stock	$21.00K	$21.00K	$1.000K
YoY Change	5.0%	2000.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$136.6M	-$96.83M	$135.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.608B	$1.521B	$1.629B
YoY Change	3.11%	-6.62%	260.41%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$45.33M	-$86.43M	$22.39M
YoY Change	3.55%	-485.99%	-128.51%
Depreciation, Depletion And Amortization	$5.978M	$7.048M	$5.630M
YoY Change	-0.3%	25.19%	36.68%
Cash From Operating Activities	-$25.38M	-$35.49M	-$50.69M
YoY Change	-37.98%	-29.99%	25.76%
INVESTING ACTIVITIES
Capital Expenditures	$1.875M	$6.924M	$10.54M
YoY Change	-133.45%	-34.3%	529.19%
Acquisitions
YoY Change
Other Investing Activities	-$135.0K	-$554.0K	-$1.077M
YoY Change	-88.35%	-48.56%	-99.76%
Cash From Investing Activities	-$2.010M	-$7.478M	-$11.62M
YoY Change	-70.29%	-35.62%	334.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$24.68M
YoY Change			1122.99%
Cash From Financing Activities	0.000	$8.000K	$399.7M
YoY Change	-100.0%	-100.0%	146.16%
NET CHANGE
Cash From Operating Activities	-25.38M	-$35.49M	-$50.69M
Cash From Investing Activities	-2.010M	-$7.478M	-$11.62M
Cash From Financing Activities	0.000	$8.000K	$399.7M
Net Change In Cash	-27.39M	-$42.78M	$337.1M
YoY Change	-41.86%	-112.69%	182.98%
FREE CASH FLOW
Cash From Operating Activities	-$25.38M	-$35.49M	-$50.69M
Capital Expenditures	$1.875M	$6.924M	$10.54M
Free Cash Flow	-$27.26M	-$42.42M	-$61.23M
YoY Change	-22.83%	-30.73%	45.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001819395
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#AdditionalPaidInCapital
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39907
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SONDER HOLDINGS INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2097088
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	101 15th Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94103
CY2023Q1	dei	City Area Code CityAreaCode	617
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	300-0956
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	219282857	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	217968000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	246624000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	28436000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42562000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1346000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	972000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6990000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5613000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	5128000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	8066000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	12708000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10065000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	271230000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	312930000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35432000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34926000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1201007000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1209486000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13791000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16270000	usd
CY2023Q1	us-gaap	Assets Assets	1521460000	usd
CY2022Q4	us-gaap	Assets Assets	1573612000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14093000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16082000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18230000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20131000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	16497000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	14418000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	58424000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41664000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	172422000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	158346000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	279666000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	250641000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1156913000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1166538000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	179665000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	172950000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2043000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3430000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1618287000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1593559000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	959789000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	947601000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10348000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12985000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1066985000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-980554000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-96827000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-19947000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1521460000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1573612000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	120738000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80466000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	92033000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	73896000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	56157000	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	48267000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32745000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36981000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6580000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7625000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15836000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9461000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	2130000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	205481000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	176230000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-84743000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-95764000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5707000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8202000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	110000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14895000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1498000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	73177000	usd
CY2023Q1	sond	Debt Conversion Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtConversionGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	0	usd
CY2022Q1	sond	Debt Conversion Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtConversionGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	29512000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2712000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2624000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1607000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	106758000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86350000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10994000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	81000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1406000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9557000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2637000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1999000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-89068000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12962000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-19947000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	sond	Stock Issued During Period Value Conversion Of Exchangeable Stock StockIssuedDuringPeriodValueConversionOfExchangeableStock	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12180000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2023Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-2637000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-96827000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-764406000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	873000	usd
CY2022Q1	sond	Adjustments To Additional Paid In Capital Liability Reclassified To Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalLiabilityReclassifiedToEquityComponentOfConvertibleDebt	2111000	usd
CY2022Q1	sond	Stock Issued During Period Value Conversion Of Notes StockIssuedDuringPeriodValueConversionOfNotes	159173000	usd
CY2022Q1	sond	Stock Issued During Period Value Conversion Of Preferred Stock StockIssuedDuringPeriodValueConversionOfPreferredStock	518761000	usd
CY2022Q1	sond	Stock Issued During Period Value Conversion Of Exchangeable Stock StockIssuedDuringPeriodValueConversionOfExchangeableStock	49733000	usd
CY2022Q1	sond	Stock Issued During Period Value Conversion Of Common Stock Reverse Recapitalization StockIssuedDuringPeriodValueConversionOfCommonStockReverseRecapitalization	267362000	usd
CY2022Q1	sond	Stock Issued During Period Value Spac Warrants Reverse Recapitalization StockIssuedDuringPeriodValueSPACWarrantsReverseRecapitalization	25985000	usd
CY2022Q1	sond	Stock Issued During Period Value Earnout Liability StockIssuedDuringPeriodValueEarnoutLiability	98117000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8750000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6680000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2022Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	1999000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	135988000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7048000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5630000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12180000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6680000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	45627000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	37646000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	2311000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2379000	usd
CY2023Q1	sond	Capitalization Of Interest On Long Term Debt CapitalizationOfInterestOnLongTermDebt	6345000	usd
CY2022Q1	sond	Capitalization Of Interest On Long Term Debt CapitalizationOfInterestOnLongTermDebt	0	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	368000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-3007000	usd
CY2023Q1	sond	Debt Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	0	usd
CY2022Q1	sond	Debt Gain Loss On Share Settle Redemption Feature And Conversion Of Debt DebtGainLossOnShareSettleRedemptionFeatureAndConversionOfDebt	29512000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	110000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14895000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1498000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	73177000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-622000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-682000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1962000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3233000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3055000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	9408000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-332000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4429000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2026000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22009000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2060000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4742000	usd
CY2023Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	2020000	usd
CY2022Q1	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	2963000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	16703000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15253000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-33695000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5200000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	79000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3165000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35492000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50693000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6924000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10539000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	554000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1077000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7478000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11616000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	159225000	usd
CY2023Q1	sond	Repayment Of Debt And Payment Of Early Termination Fees RepaymentOfDebtAndPaymentOfEarlyTerminationFees	0	usd
CY2022Q1	sond	Repayment Of Debt And Payment Of Early Termination Fees RepaymentOfDebtAndPaymentOfEarlyTerminationFees	27745000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	325928000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	58555000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	873000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399726000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-327000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42782000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	337090000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289186000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69941000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246404000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	407031000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	381000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	713000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1873000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	51000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1789000	usd
CY2023Q1	us-gaap	Notes Reduction NotesReduction	0	usd
CY2022Q1	us-gaap	Notes Reduction NotesReduction	159172000	usd
CY2023Q1	sond	Noncash Or Part Noncash Acquisition Conversion Of Warrants Amount NoncashOrPartNoncashAcquisitionConversionOfWarrantsAmount	0	usd
CY2022Q1	sond	Noncash Or Part Noncash Acquisition Conversion Of Warrants Amount NoncashOrPartNoncashAcquisitionConversionOfWarrantsAmount	1243000	usd
CY2023Q1	sond	Conversion Of Stock Warrants Amount Converted ConversionOfStockWarrantsAmountConverted	0	usd
CY2022Q1	sond	Conversion Of Stock Warrants Amount Converted ConversionOfStockWarrantsAmountConverted	2111000	usd
CY2023Q1	sond	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	0	usd
CY2022Q1	sond	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	98117000	usd
CY2023Q1	sond	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	0	usd
CY2022Q1	sond	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	25985000	usd
CY2023Q1	sond	Noncash Or Part Cash Transaction Issuance Of Delayed Draw Warrants NoncashOrPartCashTransactionIssuanceOfDelayedDrawWarrants	0	usd
CY2022Q1	sond	Noncash Or Part Cash Transaction Issuance Of Delayed Draw Warrants NoncashOrPartCashTransactionIssuanceOfDelayedDrawWarrants	5598000	usd
CY2023Q1	sond	Conversion Of Post Combination Exchangeable Shares ConversionOfPostCombinationExchangeableShares	0	usd
CY2022Q1	sond	Conversion Of Post Combination Exchangeable Shares ConversionOfPostCombinationExchangeableShares	49733000	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	518750000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	217968000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	406348000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	28436000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	683000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246404000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	407031000	usd
CY2023Q1	sond	Variable Interest Entity Number Of Entities VariableInterestEntityNumberOfEntities	1	entity
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expense during the reporting periods. Such significant management estimates include the fair value of share-based awards, estimated useful life of long-lived assets, bad-debt allowances, valuation of intellectual property and intangible assets, contingent liabilities, valuation allowance for deferred tax assets, and valuation of non-routine complex transactions, such as recognition of the Earn Out Liability and SPAC Warrants (both as defined below), among others. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts reported in previous condensed consolidated financial statements have been reclassified to conform to current period presentation. These reclassifications did not affect previously reported amounts of net income, total assets, or total stockholders’ deficit.</span></div>
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	11400000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14895000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	106758000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10994000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1406000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9557000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	12962000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q1	sond	Stock Issued During Period Value Spac Warrants Reverse Recapitalization StockIssuedDuringPeriodValueSPACWarrantsReverseRecapitalization	25985000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	930519000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-803849000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	135988000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14895000	usd
CY2022Q1	sond	Recognition Of Spac Warrants Reverse Recapitalization RecognitionOfSPACWarrantsReverseRecapitalization	25985000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	120738000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80466000	usd
CY2022	sond	Noncash Or Part Noncash Acquisition Derivative Liabilities Assumed NoncashOrPartNoncashAcquisitionDerivativeLiabilitiesAssumed	98117000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	30322000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	189597000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	183245000	usd
CY2023Q1	sond	Debt Instrument Delayed Draw Warrants DebtInstrumentDelayedDrawWarrants	4761000	usd
CY2022Q4	sond	Debt Instrument Delayed Draw Warrants DebtInstrumentDelayedDrawWarrants	4945000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5171000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5350000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	179665000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	172950000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	28400000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	42600000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	75259000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	62947000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	632000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1501000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	643000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	77392000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	63592000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	68215000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	49765000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	38527000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	114900000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	77400000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	65100000	usd
CY2022Q1	sond	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4686
CY2022Q1	sond	Shares Authorized SharesAuthorized	690000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	142724687	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	126055660	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12180000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6680000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1406000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9557000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219105342	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	176326658	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	10963000	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2022Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2727000	usd
CY2023Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2022Q1	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-29512000	usd
CY2023Q1	sond	Dilutive Securities Effect On Basic Earnings For Each Share Stock Warrants DilutiveSecuritiesEffectOnBasicEarningsForEachShareStockWarrants	0	usd
CY2022Q1	sond	Dilutive Securities Effect On Basic Earnings For Each Share Stock Warrants DilutiveSecuritiesEffectOnBasicEarningsForEachShareStockWarrants	-14895000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-86431000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-30717000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219105342	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	176326658	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4499600	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219105342	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	171827058	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86429741	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	65512608	shares
CY2023Q1	sond	Number Of Surety Providers NumberOfSuretyProviders	5	surety_provider
CY2023Q1	sond	Loss Contingency Estimated Accrual Liability Related To Tax Matters LossContingencyEstimatedAccrualLiabilityRelatedToTaxMatters	8300000	usd
CY2022Q4	sond	Loss Contingency Estimated Accrual Liability Related To Tax Matters LossContingencyEstimatedAccrualLiabilityRelatedToTaxMatters	7900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	81000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0009
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0028
CY2022Q4	sond	Extension Of Post Exchangeable Shares Period ExtensionOfPostExchangeableSharesPeriod	P5Y
CY2022Q1	sond	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	58555000	usd
CY2022Q1	sond	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	267373000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	159225000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24680000	usd
CY2022Q1	sond	Reverse Recapitalization Net ReverseRecapitalizationNet	401918000	usd
CY2022Q2	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	4000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	2100000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1600000	usd

Files In Submission

Name	View Source	Status
0001819395-23-000074-index-headers.html	Edgar Link	pending
0001819395-23-000074-index.html	Edgar Link	pending
0001819395-23-000074.txt	Edgar Link	pending
0001819395-23-000074-xbrl.zip	Edgar Link	pending
exhibit101-sonder_offerx.htm	Edgar Link	pending
exhibit101-sonder_offerx001.jpg	Edgar Link	pending
exhibit101-sonder_offerx002.jpg	Edgar Link	pending
exhibit101-sonder_offerx003.jpg	Edgar Link	pending
exhibit101-sonder_offerx004.jpg	Edgar Link	pending
exhibit101-sonder_offerx005.jpg	Edgar Link	pending
exhibit101-sonder_offerx006.jpg	Edgar Link	pending
exhibit101-sonder_offerx007.jpg	Edgar Link	pending
exhibit101-sonder_offerx008.jpg	Edgar Link	pending
exhibit101-sonder_offerx009.jpg	Edgar Link	pending
exhibit101-sonder_offerx010.jpg	Edgar Link	pending
exhibit101-sonder_offerx011.jpg	Edgar Link	pending
exhibit101-sonder_offerx012.jpg	Edgar Link	pending
exhibit101-sonder_offerx013.jpg	Edgar Link	pending
exhibit101-sonder_offerx014.jpg	Edgar Link	pending
exhibit101-sonder_offerx015.jpg	Edgar Link	pending
exhibit101-sonder_offerx016.jpg	Edgar Link	pending
exhibit101-sonder_offerx017.jpg	Edgar Link	pending
exhibit101-sonder_offerx018.jpg	Edgar Link	pending
exhibit101-sonder_offerx019.jpg	Edgar Link	pending
exhibit101-sonder_offerx020.jpg	Edgar Link	pending
exhibit101-sonder_offerx021.jpg	Edgar Link	pending
exhibit101-sonder_offerx022.jpg	Edgar Link	pending
exhibit101-sonder_offerx023.jpg	Edgar Link	pending
exhibit101-sonder_offerx024.jpg	Edgar Link	pending
exhibit101-sonder_offerx025.jpg	Edgar Link	pending
exhibit311-sec302certifica.htm	Edgar Link	pending
exhibit312-sec302certifica.htm	Edgar Link	pending
exhibit321-sec906certifica.htm	Edgar Link	pending
exhibit322-sec906certifica.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sond-20230331.htm	Edgar Link	pending
sond-20230331.xsd	Edgar Link	pending
sond-20230331_cal.xml	Edgar Link	unprocessable
sond-20230331_def.xml	Edgar Link	unprocessable
sond-20230331_lab.xml	Edgar Link	unprocessable
sond-20230331_pre.xml	Edgar Link	unprocessable
sond-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SOND
Sonder Holdings Inc. Stock $sond

2023 Q2 Form 10-Q Financial Statement

#000181939523000074 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOND Sonder Holdings Inc. Stock $sond

2023 Q2 Form 10-Q Financial Statement

#000181939523000074 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOND
Sonder Holdings Inc. Stock $sond